Neutrophil-derived ~175 bp cfDNA fragments amplify inflammaging through TLR9 recognition of hypomethylated CpG motifs

Hypothesis

We propose that the increase in neutrophil-derived cfDNA fragments of approximately 175 bp observed in older plasma carries a distinct methylation signature characterized by reduced CpG methylation at specific immunostimulatory motifs. These hypomethylated motifs are more accessible to endosomal TLR9, leading to heightened NF‑κB signaling and proinflammatory cytokine release. Consequently, the 175 bp neutrophil cfDNA fraction acts as a mechanistic link between age‑related epigenetic drift and inflamm‑aging.

Rationale

• Aging is associated with enrichment of ~175 bp cfDNA fragments and a shift toward neutrophil origins [PMC11318736]
• Hypomethylated cfDNA enhances immunostimulatory potential via TLR9 [PMC11318736]
• Nucleosome spacing becomes irregular with age, potentially protecting certain fragments from complete degradation and preserving the 175 bp size [PMC6351822]
• Neutrophil extracellular traps (NETs) release DNA fragments of similar length, suggesting a cellular source that aligns with the observed size shift

Predictions

1. Isolating the 175–180 bp cfDNA fraction from plasma of young versus old donors will show a higher proportion of neutrophil-specific methylation markers in the older group
2. Within this fraction, CpG sites located in TLR9‑recognition motifs (e.g., unmethylated CpG dinucleotides flanked by purines) will exhibit significantly lower methylation levels in older individuals compared with younger individuals
3. Synthetic reconstitution of hypomethylated 175 bp neutrophil‑derived cfDNA fragments will provoke greater TNF‑α and IL‑6 secretion from human macrophages in vitro than methylated counterparts, an effect blocked by TLR9 antagonists
4. In vivo, administering a TLR9 inhibitory oligonucleotide to aged mice will reduce circulating proinflammatory cytokines without altering total cfDNA concentration, specifically diminishing the activity of the 175 bp neutrophil fraction

Experimental Design

Sample preparation

• Collect plasma from age‑stratified human cohorts (20‑30, 60‑70, 80+ years)
• Separate cfDNA by size‑exclusion chromatography or agarose gel electrophoresis to isolate 150‑200 bp fraction
• Perform cfSort‑based deconvolution to quantify neutrophil contribution [PubMed37399400]

Methylation analysis

• Use bisulfite sequencing targeting a panel of 48 age‑associated CpG sites plus a set of TLR9‑motif CpGs
• Compare methylation percentages between age groups and cell‑origin fractions

Functional assays

• Isolate the 175 bp fraction; treat differentiated THP‑1 macrophages (or primary human monocytes) with equal DNA amounts
• Measure cytokine secretion (ELISA) and NF‑κB activation (phospho‑p65 Western blot)
• Include controls: methylated fraction, TLR9 antagonist (ODN2088), and DNAse treatment

In vivo validation

• Use aged (18‑month) C57BL/6 mice; administer TLR9 antagonist or control via intraperitoneal injection
• After 24 h, collect serum for cytokine profiling and plasma for cfDNA size distribution and neutrophil methylation markers

Expected outcomes

• If the hypothesis is correct, older samples will show increased neutrophil-derived 175 bp cfDNA with hypomethylated TLR9 motifs, correlating with higher inflammatory readouts
• TLR9 blockade will specifically dampen the inflammatory response linked to this fraction, confirming causality
• Failure to observe these patterns would falsify the proposed mechanism